The Global Cardiac Ablation Devices Market size is projected to grow at a CAGR of around 16.53% during the forecast period, i.e., 2022-27. According to MarkNtel Advisors Study.

Global Cardiac Ablation Devices Market Driver:

Surging Incidences of Atrial Fibrillation Worldwide: Atrial Fibrillation (AF) has been a common type of arrhythmia in which the heart beats rapidly or slowly. It can either result in strokes or heart failure and happens mainly due to excessive intake of alcohol & caffeine, sedentary lifestyle, smoking, consumption of dietary supplements, etc. Due to this, heart diseases, high blood pressure, chronic heart diseases, thyroid, obesity, etc., have increased substantially. AF often coexists with heart failure as well as obesity in the aging population.

Moreover, the prevalence of AF is higher among people aged 65 & above. The escalating geriatric population in both developed & developing countries like the US, Japan, countries of Western Europe, and India & China are expected to propel the incidence rate of AF in the coming years.

As a result, it would accelerate the demand for cardiac ablation devices over the forecast years. Japan, China, etc., are amongst the most impacted countries by AFib in 2022. With the continuous growth in the aging population in Japan, an estimated 1 million patients are expected to have AFib by 2030, as reported by the European Society of Cardiology.

Besides, the steady rise in AFib-related hospital admissions, mounting inclination toward cardiac ablation for AFib treatment, and investments made by several companies in this sector to maximize their revenue are other crucial aspects anticipated to drive the market during 2022-27.

In 2021, Boston Scientific acquired Farapulse for USD 295 million to expand its market share of cardiac Ablation devices. The company had been an investor of 27% in Farapulse since 2014, but the recent acquisition would provide 100% ownership to Boston Scientific.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/cardiac-ablation-devices-market.html

Key Market Reports Highlights

·        Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Full Report including(TOC+ List of Table and Figures) : https://www.marknteladvisors.com/research-library/cardiac-ablation-devices-market.html

Global Cardiac Ablation Devices Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2021

-Historical Period: 2017 to 2020

-Forecast Period: 2022 to 2027

• By Product
• Water-cooled radiofrequency ablation
• Temperature-Controlled Radiofrequency Ablators
• Tissue Contact Probes
• Microwave Thermotherapy Devices
• Others (Robotic Catheter Manipulation Systems, Ultrasound Ablation Systems, etc.)
• By Technology
• Radiofrequency (RF) Ablation
• Cryoablation Device
• Laser Ablation
• Electrical Ablators
• Microwave Ablation
• Ultrasound Ablation
• By Application
• Cardiac Rhythm Management
• Tachycardia
• Atrial Fibrillation and Flutter
• Open Surgery
• By End-Users
• In-patient
• Outpatient
• By Region
• North America
• South America
• Europe
• Middle East & Africa
• Asia-Pacific

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including - Abbott Laboratories, Medtronic plc, Olympus Corporation, Johnson & Johnson (Biosense Webster, Inc.), Boston Scientific Corporation, CONMED Corporation, AngioDynamics, Inc., CardioFocus Inc., Stryker Corporation, MicroPort Inc., Stereotaxis Inc., Teleflex Incorporated, Lepu Medical Technology, Avanos Medical, AtriCure Others are looking forward to strengthening their market positions.

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/cardiac-ablation-devices-market.html

Data-Driven Insights Backed by Proven Research

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release